// SECTOR INVESTOR DOSSIER
Investors in biopharmaceutical
11 investors with active positions in biopharmaceutical unicorns — combined exposure across this sector $11B in paper valuation.
Goldman Sachs
INVESTMENT BANK1 company in sector · $1B
↑ 31% hit↓ 44% missDANGEROUSMorgan Stanley
INVESTMENT BANK1 company in sector · $1B
↑ 41% hit↓ 51% missDANGEROUSJPMorgan Chase
INVESTMENT BANK1 company in sector · $1B
↑ 23% hit↓ 49% missDANGEROUSHillhouse Capital
VC FUND1 company in sector · $1B
↑ 26.3% hit↓ 36.8% missDANGEROUSTemasek Holdings
SOVEREIGN1 company in sector · $1B
↑ 15% hit↓ 54% missTOO BIG TO FAILQiming Venture Partners
VC FUND1 company in sector · $1B
↑ 9.1% hit↓ 36.4% missARMEDFidelity International
VC FUND1 company in sector · $1B
OrbiMed
VC FUND1 company in sector · $1B
Vivo Capital
VC FUND1 company in sector · $1B
Lilly Asia Ventures
VC FUND1 company in sector · $1B
Capital Today
VC FUND1 company in sector · $1B